Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study

Nikolaos Kentepozidis,A Soultati,Stylianos Giassas,N. Vardakis,A. Kalykaki,Athanasios Kotsakis,Elisavet Papadimitraki,Nikolaos Pantazopoulos,V. Bozionellou,V. Georgoulias

Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study

2012

Nikolaos Kentepozidis
A Soultati
Stylianos Giassas
N. Vardakis
A. Kalykaki
Athanasios Kotsakis
Elisavet Papadimitraki
Nikolaos Pantazopoulos
V. Bozionellou
V. Georgoulias

Introduction To evaluate the efficacy and tolerance of biweekly paclitaxel and carboplatin combination in patients with castration-resistant prostate cancer.

Keywords:

Carboplatin
Prostate cancer
Phases of clinical research
Paclitaxel
Medicine
Oncology
Internal medicine
in patient
salvage treatment
pharmacology toxicology
castration resistant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations